Clinical validation of the ThyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology

被引：58
|
作者：
Nikiforov, Yuri E. [1 ]
Baloch, Zubair W. [2 ]
机构：
[1] Univ Pittsburgh, Dept Pathol, 3477 Euler Way,Rm 8031, Pittsburgh, PA 15213 USA
[2] Hosp Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
CANCER CYTOPATHOLOGY | 2019年 / 127卷 / 04期
基金：
美国国家卫生研究院;
关键词：
benign call rate; indeterminate FNA; next generation sequencing; thyroid nodule; ThyroSeq; FINE-NEEDLE-ASPIRATION; UNDETERMINED SIGNIFICANCE/FOLLICULAR LESION; CANCER-DIAGNOSIS; BETHESDA SYSTEM; HIGH PREVALENCE; MANAGEMENT; MUTATIONS; CARCINOMA; NEOPLASM; CYTOPATHOLOGY;
D O I：
10.1002/cncy.22112
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 230
页数：6
相关论文
共 50 条
  • [1] Analytical Performance of the ThyroSeq v3 Genomic Classifier for Cancer Diagnosis in Thyroid Nodules
    Nikiforova, Marina N.
    Mercurio, Stephanie
    Wald, Abigail I.
    de Moura, Michelle Barbi
    Callenberg, Keith
    Santana-Santos, Lucas
    Gooding, William E.
    Yip, Linwah
    Ferris, Robert L.
    Nikiforov, Yuri E.
    CANCER, 2018, 124 (08) : 1682 - 1690
  • [2] Surgical Outcomes of Thyroid Nodules Positive for Gene Expression Alterations Using ThyroSeq V3 Genomic Classifier
    Salameh, Samer
    Rajab, Mohannad
    Forest, Veronique-Isabelle
    Pusztaszeri, Marc
    Payne, Richard J. J.
    CANCERS, 2023, 15 (01)
  • [3] Comparison of Diagnostic Accuracy between ThyroSeq v2 and ThyroSeq v3 Molecular Test for Indeterminate Thyroid Nodules
    Lin, Benjamin
    Zelonis, Michele
    Lin, Fan
    Liu, Haiyan
    LABORATORY INVESTIGATION, 2019, 99
  • [4] Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology
    Valderrabano, Pablo
    Khazai, Laila
    Leon, Marino E.
    Thompson, Zachary J.
    Ma, Zhenjun
    Chung, Christine H.
    Hallanger-Johnson, Julie E.
    Otto, Kristen J.
    Rogers, Kara D.
    Centeno, Barbara A.
    McIver, Bryan
    ENDOCRINE-RELATED CANCER, 2017, 24 (03) : 127 - 136
  • [5] Comparison of Diagnostic Accuracy between ThyroSeq v2 and ThyroSeq v3 Molecular Test for Indeterminate Thyroid Nodules
    Lin, Benjamin
    Zelonis, Michele
    Lin, Fan
    Liu, Haiyan
    MODERN PATHOLOGY, 2019, 32
  • [6] Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules
    Marcadis, Andrea R.
    Valderrabano, Pablo
    Ho, Allen S.
    Tepe, Justin
    Swartzwelder, Christina E.
    Byrd, Serena
    Sacks, Wendy L.
    Untch, Brian R.
    Shaha, Ashok R.
    Xu, Bin
    Lin, Oscar
    Ghossein, Ronald A.
    Wong, Richard J.
    Marti, Jennifer L.
    Morris, Luc G. T.
    SURGERY, 2019, 165 (01) : 17 - 24
  • [7] DETECTING THYROID CANCER: COMPARATIVE ANALYSIS OF AFIRMA GENOMIC SEQUENCE CLASSIFIER VERSUS THYROSEQ V3 GENOMIC CLASSIFIER
    Hitscherich, K. J.
    Hernandez, M.
    Hanlon, A.
    Sienko, D.
    Tiesi, G.
    BRITISH JOURNAL OF SURGERY, 2020, 107 : 11 - 11
  • [8] Detecting Thyroid Cancer: Comparative Analysis of Afirma Genomic Sequence Classifier Versus Thyroseq v3 Genomic Classifier
    Hitscherich, K. J.
    Hernandez, M.
    Hanlon, A.
    Sienko, D.
    Tiesi, G.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S91 - S92
  • [9] A benign genomic classifier for thyroid nodules with indeterminate cytology: a critical appraisal
    Wiseman, Sam M.
    GLAND SURGERY, 2012, 1 (02) : 87 - 88
  • [10] The role of ThyroSeq V3 testing in the management of patients with indeterminate thyroid nodules on fine needle aspiration
    Selvaggi, Suzanne M.
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (07) : 838 - 841
12345